About 4 results found for searched term "437-50-3" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M17922 | Gentisin | Xanthones |
| Gentisin | ||
| M8257 | SB 328437 | CCR |
| SB328437; SB-328437 | ||
| SB-328437 is a potent, selective non-peptide CCR3 antagonist with an IC50 of 4.5 nM. SB 328437 inhibits the recruitment and migration of eosinophils in allergen models of models. SB 328437 suppresses the Th2-mediated eosinophil infiltration in the airways. | ||
| M21069 | AZ13824374 | Epigenetic Reader Domain |
| AZ13824374 is an in vitro ATAD2 inhibitor with anti-proliferative activity against breast cancer. pIC50 of AZ13824374 against ATAD2 in the ATAD2 FRET and ATAD2 NanoBRET assays were 8.2 and 6.2, respectively. | ||
| M31094 | Retatrutide acetate | Glucagon Receptor |
| LY3437943 acetate | ||
| Retatrutide (LY3437943) acetate is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide acetate inhibits for human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
